Redefining the Future of Cardiac Rhythm Care

StimCardio Medical is a clinical-stage medical device company developing non-invasive neuromodulation technologies for cardiovascular applications. Our work is guided by clinical insight, key opinion leaders' support, engineering rigor, and a long-term view of how cardiac rhythm disorders are managed.

Our Mission

Our mission is to advance neuromodulation as a therapeutic approach for cardiac rhythm disorders through non-invasive, wearable technologies that empower patients to actively participate in their own care and to support personalized, at-home disease management, beginning with atrial fibrillation.

Black StimCardio fitness smartwatch displaying time 14:50, heart rate 76, and battery and Bluetooth icons on screen, with two metallic buttons on the band.

Our Vision

We envision a future in which neuromodulation is an integral, evidence-based component of cardiovascular disease management, enabling earlier, more continuous, and individualized approaches to care.

About StimCardio

Blue circle with white heartbeat line icon in the center surrounded by concentric white curved lines on a black background.

StimCardio was founded to overcome the 
limitations of invasive, drug-based, and clinic-centric arrhythmia care.

Icon of a human head with circuit lines connecting to nodes, representing artificial intelligence.

We are building a platform that extends treatment beyond the clinic by integrating neuromodulation, continuous physiological sensing, and adaptive intelligence into daily life.

Blue heart with a heartbeat line icon surrounded by concentric white curved lines on a dark background.

Our initial focus is atrial fibrillation, with a scalable architecture designed to support future cardiovascular and neuro-cardiac applications.

Our Team

StimCardio has a multidisciplinary team with experience across cardiovascular medicine, neuromodulation, biomedical engineering, data science, and medical device development. The team operates across key innovation hubs, with headquarters in Los Angeles, a technology center in Austin, and scientific operations in Tel Aviv.

Linkedin

Amos Ziv

Founder and CSO

Amos Ziv is an entrepreneur, researcher, and clinical research scientist with over 20 years of experience in integrative cardiovascular support. Prior to founding StimCardio, he established and managed hospital-based research centers and private clinics, where he led clinical trials in cardiovascular prevention and acute care. He serves as a lecturer at leading Israeli academic institutions. Amos holds a B.Sc. in Biology and an M.Sc. in Integrative Medicine, with additional training in biostatistics, clinical trial design, and healthcare innovation. He brings more than a decade of medical device industry experience, combining entrepreneurial leadership with deep clinical insight.

Linkedin

Tsahi Holand

Co-Founder and CTO

Tsahi Holand is a seasoned technology leader with over two decades of experience leading advanced, cross-platform R&D teams and processes. Prior to co-founding StimCardio, he held senior engineering and R&D leadership roles at Elbit Systems, where he led the development of real-time embedded software, FPGA-based systems, and complex signal-processing solutions for mission-critical platforms. Tsahi holds an M.Sc. in Signal Processing from Tel Aviv University and a B.Sc. in Electrical and Computer Engineering from Ben-Gurion University of the Negev.

Linkedin

Amir Soltanianzadeh

CEO

Amir Soltanianzadeh is a medtech executive, entrepreneur, and investor with a proven track record of building and scaling medical device companies. He previously co-founded and served as CEO of Spine Align, which was acquired by a public orthopedic industry leader in 2021. Amir is also the founder and Managing Partner of Solardis Health Ventures, where he invests in breakthrough medical device technologies across cardiovascular and digital health fields. He holds a B.Sc. in Biomedical Engineering from Boston University and an M.S.E in Bioengineering Innovation & Design from Johns Hopkins University.

Linkedin

Leena Kadakia

VP, Regulatory and Quality

Leena is a regulatory and quality affairs executive with over 20 years of experience advancing innovative medical technologies from concept through global commercialization. She brings expertise in global regulatory strategy, FDA submissions (including 510(k), IDE, and De Novo pathways), design controls, verification and validation, risk management, and clinical affairs. Prior to joining StimCardio, Leena served as VP of Regulatory Affairs at RefleXion Medical and consulted for multiple companies. She holds a B.Sc. in Chemical Engineering from MIT and an M.Sc. in Biomedical Engineering from Johns Hopkins University. Leena is RAC-US certified and serves as an instructor in the Regulatory Affairs program at UCSC Silicon Valley Extension.

Linkedin

Adi Benari

Clinical Trials Manager

Adi Benari is a clinical affairs professional with over a decade of experience leading and executing global clinical trials in medical device companies. She currently serves as Clinical Trials Manager at StimCardio, overseeing clinical investigations in the U.S. and Israel and coordinating cross-functional teams to ensure compliant study design, execution, and monitoring. Adi holds an M.Sc. in Biotechnology Engineering from the Technion – Israel Institute of Technology and is trained in GCP and clinical research operations.

Linkedin

Eial Ferencz

Senior Full-Stack Developer

Eial Ferencz is a full-stack developer with extensive experience designing and building scalable web platforms, including server, web, and application architectures. He brings a strong background in end-to-end product development, with a focus on performance, reliability, and adaptability to rapidly evolving technologies.

Linkedin

Ram Tuvi, PhD

Staff Data Scientist

Ram Tuvi is an applied scientist specializing in the development and design of algorithms at the intersection of physics-based modeling, signal processing, and data-driven methods. He has extensive experience collaborating across teams and bridging the gap between theoretical research and high-impact technologies. Ram holds B.Sc., M.Sc. (Ben-Gurion University of the Negev), and Ph.D. (Tel Aviv University) degrees in Electrical Engineering, specializing in wave physics, inverse problems, and algorithm design. He has authored 30+ publications and contributed to multiple patent applications

Linkedin

Aziz Yuldashev

Senior Electrical Engineer

Aziz is a Senior Electrical Engineer with deep experience in digital and analog hardware design across healthcare/medical, consumer electronics, and wearable devices. He has a strong track record of leading cross-functional teams from concept through PVT/MP builds, with expertise in system-level integration that balances power, cost, and scalability. Aziz has worked in both large-scale technology and startup environments, including Meta, BioLite, Rocean, and Evolve, delivering mission-critical devices in fast-paced, ambiguous settings. His technical focus includes reliable and redundant system design, EMC/EMI compliance, and robust design-for-manufacturing (DFM) workflows. He holds a BS in Electrical Engineering from Seattle University and an AS in Electrical Engineering from North Seattle College.

Linkedin

Daniela Puzhevsky

Senior Project Manager

Daniela Puzhevsky is a Senior Project Manager with over eight years of experience in cardiology clinical research, managing multidisciplinary teams across hospital and medical device environments. She leads clinical projects and day-to-day operations at StimCardio, overseeing study execution, team coordination, and critical workflows. She brings a structured, proactive approach to advancing medical innovation. Daniela holds an MBA in Biomedical Management from The College of Management Academic Studies and a B.Sc. in Biology from Ben-Gurion University of the Negev.

Linkedin

Tamar Panin

Senior Clinical Research Associate

Tamar Panin is a Senior Clinical Research Associate with extensive experience overseeing multicenter clinical studies and ensuring full compliance with GCP and regulatory requirements. She brings a strong background in site management, study monitoring, and trial operations across medical device and clinical research settings. Tamar is a registered nurse and holds a Master’s degree in Health Systems Management and Health Technology Assessment, supporting the rigorous execution of StimCardio’s clinical programs.

Advisory Board

StimCardio is supported by an advisory board of clinicians, KOLs, researchers, and industry experts with deep experience in cardiac electrophysiology, neuromodulation, clinical research, and medical technology innovation.

Linkedin

Alexei Mlodinow

Board Chairman

Alexei Mlodinow is a surgeon, serial entrepreneur, and venture investor with a proven track record of building and scaling innovative medical technology companies. As founding CEO of SIA, he led the company through FDA clearance, commercialization, NIH funding, IDE approval for a Class III device, and eventual acquisition by Integra LifeSciences. He also co-founded RapidRona, one of the first companies with an EUA for a home PCR test kit, which was acquired in 2021. Alexei serves as a board member and/or executive for few but mighty high-growth medtech companies and is a venture partner at SPRIG Equity, a late stage venture fund with a best-in-class portfolio spanning neuromodulation, interventional cardiology, and select other sectors.

Linkedin

John Slump

Board Member

John Slump is a medtech founder, operator, and investor with a proven track record of building category-defining medical device companies from concept through commercialization and acquisition. He has served as a founder and/or executive of four medical device companies that exited for more than $1.25 billion in total transaction value. He co-founded Farapulse, which was acquired by Boston Scientific Corp. in 2021 for more than $800 million, and most recently co-founded and served as CEO of Atraverse Medical, which was acquired by Johnson & Johnson in May 2026, less than four years after founding the company. Through his investment and advisory arm, Metis MedTech, John partners with early-stage companies and provides founders with friendly capital, strategic guidance, and hands-on operational support from the pre-clinical development phase through regulatory approval, commercialization, and exit. John led the $25M Series A Financing for StimCardio Medical and serves on the company’s Board of Directors.

Prof. Vivek Y. Reddy, MD

Senior Medical Advisor

Prof. Vivek Y. Reddy, MD, is a nationally recognized leader in cardiac electrophysiology and Director of Cardiac Arrhythmia Services at The Mount Sinai Hospital and the Mount Sinai Health System. He is also the Leona M. and Harry B. Helmsley Charitable Trust Professor of Medicine in Cardiac Electrophysiology at the Icahn School of Medicine at Mount Sinai. Under his leadership, Mount Sinai serves as a lead investigator on multiple multinational clinical trials evaluating next-generation arrhythmia procedures and technologies. In 2014, Prof. Reddy implanted the first miniature leadless pacemaker in the United States at The Mount Sinai Hospital.

Linkedin

Joshua Phillips

Board Member

Joshua Phillips is a co-Founder and Managing Partner of Catalyst Health Ventures. He has been investing in medical technology for 26 years. Notable investments include Conformal Medical (acquired by WL Gore), Epitel Inc, Brixton Biosystems, Vortex Medical (acquired by AngioDynamics), BioTrove (acquired by Thermo Fisher) and Esperto Medical. He holds a B.E. In Electrical Engineering and Mathematics from Vanderbilt University and an M.B.A. From Harvard Business School.